Fabricante do Ozempic faz acordo com Re.green para restaura��o da amaz�nia

Novo Nordisk, a Danish pharmaceutical company known for producing the popular weight-loss drug Ozempic, has teamed up with Brazilian firm Re.green to restore parts of the Amazon rainforest. This initiative aims to offset the environmental impact of the drug's production, reflecting a growing trend in corporate responsibility for ecological footprints. The partnership highlights the global push for sustainable practices in the pharmaceutical industry, which could set a precedent for other companies to follow in balancing profit with ecological stewardship.